Bombardier Inc.
Bombardier Inc. is a global aerospace company within the Industrials sector, headquartered in Dorval, Canada. The firm is primarily involved in the Aerospace & Defense industry, focusing on the design, production, and distribution of business jets. Its operational reach extends across several major international…
Company description based on the data provider's company data, AI-assisted, created on 16/10/2026. Not investment advice.
1D
-0.8%
1W
+3.5%
1M
+2.2%
6M
+15.4%
YTD
+31.9%
1Y
+62.0%
2Y
+179.8%
5Y
+501.0%
10Y
+600.0%
Next earnings date
05/11/2026 (in 19 days)
Volatility around earnings
~12% stronger price swings than usual
0
STRONG BUY
2
BUY
2
HOLD
0
SELL
0
STRONG SELL
4
TOTAL · Buy
As of: 18/05/2022
P/E
22.83
P/B
-33.2
EV/EBITDA
14.08
RETURN ON EQUITY
-26.9%
NET MARGIN
8.1%
DEBT/EQUITY
-6.23
DIVIDEND YIELD
0.0%
AS OF
30/06/2026
FREE FLOAT
99.9%
FLOAT SHARES
87,014,700
AVG. DAILY VOLUME (30D)
236,493
Bombardier Inc. is a company in the Industrials sector, Aerospace & Defense industry, headquartered in Canada.
The CEO is Éric Martel, the company employs around 18,900 people.
The IPO was on 12/01/1995; the stock trades on TSX under the ticker BBD-B.TO.
4 analysts rate the stock, the consensus is Buy (as of 18/05/2022).
This is an external assessment, not a statement by Market Jury.
The next earnings date is 05/11/2026.
Around past earnings, price swings were roughly 12% stronger than usual.
Yes. The last dividend was CA$0.00 per share, ex-date 10/12/2014, paid on 31/12/2014.
The dividend yield is 0.0% (as of 30/06/2026).
Comparable stocks include MDA Space, GE Aerospace, RTX, Boeing Company, Lockheed Martin, Howmet Aerospace, General Dynamics and Northrop Grumman.
Clicking "Analyze stock" lets five strategies assess Bombardier against fixed, published rules and judge it bullish, neutral or bearish. The jury states where it disagrees. A free account starts with 5 credits, a quick check costs 1 credit, a full analysis 2 credits.
Not investment advice. Past performance is not an indicator of future results.